Chile vs Uganda: Reported rate of new cervical cancer cases
Chile
16.68 per 100,000 women
in 2017
Uganda
36.14 per 100,000 women
in 2017
Chile rank
3rd
Uganda rank
1st
Reported rate of new cervical cancer cases over time
- Chile
- Uganda
How they compare
Uganda currently reports 36.14 per 100,000 women against 16.68 per 100,000 women in Chile, a difference of 19.46 per 100,000 women.
That makes Uganda's figure about 2.2 times Chile's.
Across all 20 years both countries report, Uganda has been ahead every year.
Chile ranks 3rd and Uganda ranks 1st of 46 countries.
Uganda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 22.15 per 100,000 women | 41.44 per 100,000 women | 19.29 per 100,000 women | Uganda |
| 2000s | 17.54 per 100,000 women | 50.59 per 100,000 women | 33.04 per 100,000 women | Uganda |
| 2010s | 12.75 per 100,000 women | 50.19 per 100,000 women | 37.44 per 100,000 women | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Chile or Uganda?
- Uganda, at 36.14 per 100,000 women against 16.68 per 100,000 women in Chile as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Chile and Uganda?
- 19.46 per 100,000 women, with Uganda ahead.
- How many years of comparable data are there for Chile and Uganda?
- 20 years are reported by both, from 1998 to 2017.
- How do Chile and Uganda rank globally for reported rate of new cervical cancer cases?
- Chile ranks 3rd and Uganda ranks 1st of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.